DHGWA
TRAW icon

Dixon Hughes Goodman Wealth Advisors’s Traws Pharma TRAW Stock Holding History

Dixon Hughes Goodman Wealth Advisors’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$0 Hold
1
– – ﹤0.01% 1090
2021
Q4 		$0 Buy
+1
New +$80 ﹤0.01% 865

Other funds holding TRAW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dixon Hughes Goodman Wealth Advisors's TRAW Position: Q1 2022 in Review

Dixon Hughes Goodman Wealth Advisors held its Traws Pharma (TRAW) position steady in Q1 2022 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1090.

Dixon Hughes Goodman Wealth Advisors first reported a position in TRAW in Q4 2021 and has held it in 2 quarters since. 30 funds tracked by Wall St. Rank hold TRAW as of Q1 2022.

  • Dixon Hughes Goodman Wealth Advisors held 1 share of Traws Pharma worth $0 as of Q1 2022.
  • Dixon Hughes Goodman Wealth Advisors left its Traws Pharma share count unchanged in Q1 2022.
  • Traws Pharma made up ﹤0.01% of Dixon Hughes Goodman Wealth Advisors's portfolio in Q1 2022, its #1090 holding.
  • Dixon Hughes Goodman Wealth Advisors first reported a position in Traws Pharma in Q4 2021 and has held it in 2 quarters since.
  • 30 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2022.

Based on Dixon Hughes Goodman Wealth Advisors's 13F filing for Q1 2022, filed 4 Apr 2022.